BIOCEPT INC Quarterly Cost of Revenue in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Biocept Inc quarterly/annual Cost of Revenue history and growth rate from Q1 2013 to Q2 2023.
  • Biocept Inc Cost of Revenue for the quarter ending June 30, 2023 was $2.55M, a 68.2% decline year-over-year.
  • Biocept Inc Cost of Revenue for the twelve months ending June 30, 2023 was $15.7M, a 60.5% decline year-over-year.
  • Biocept Inc annual Cost of Revenue for 2022 was $28.4M, a 24.7% decline from 2021.
  • Biocept Inc annual Cost of Revenue for 2021 was $37.8M, a 77% increase from 2020.
  • Biocept Inc annual Cost of Revenue for 2020 was $21.3M, a 94.4% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $15.7M $2.55M -$5.47M -68.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $21.1M $3.03M -$7.31M -70.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $28.4M $4.31M -$5.72M -57.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $34.2M $5.78M -$5.49M -48.7% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-04-17
Q2 2022 $39.7M $8.02M +$561K +7.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $39.1M $10.3M +$1.33M +14.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $37.8M $10M +$18.1K +0.18% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $37.7M $11.3M +$5.41M +92.3% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-04-17
Q2 2021 $32.3M $7.46M +$4.94M +196% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 $27.4M $9.01M +$6.06M +206% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $21.3M $10M +$7.14M +249% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-05
Q3 2020 $14.2M $5.86M +$3.03M +107% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-02-15
Q2 2020 $11.2M $2.52M -$155K -5.81% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $11.3M $2.95M +$347K +13.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $11M $2.87M +$437K +17.9% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-27
Q3 2019 $10.5M $2.83M +$351K +14.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $10.2M $2.67M -$26.3K -0.98% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $10.2M $2.6M +$164K +6.76% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $10.1M $2.44M +$75.4K +3.19% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $9.98M $2.48M -$5.14K -0.21% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-27
Q2 2018 $9.98M $2.7M +$331K +14% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-27
Q1 2018 $9.65M $2.43M +$305K +14.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-27
Q4 2017 $9.35M $2.36M +$460K +24.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $8.88M $2.49M +$611K +32.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-29
Q2 2017 $8.27M $2.37M +$699K +41.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-29
Q1 2017 $7.57M $2.13M +$655K +44.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-29
Q4 2016 $6.92M $1.9M +$624K +48.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 $6.3M $1.88M +$717K +61.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-28
Q2 2016 $5.58M $1.67M +$656K +64.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-28
Q1 2016 $4.92M $1.47M +$327K +28.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-28
Q4 2015 $4.6M $1.28M +$661K +108% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 $3.94M $1.16M +$622K +115% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-28
Q2 2015 $3.31M $1.01M +$654K +182% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-28
Q1 2015 $2.66M $1.15M +$489K +74.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-28
Q4 2014 $2.17M $615K +$44.4K +7.78% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 $2.13M $538K -$80.9K -13.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 $2.21M $359K -$234K -39.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 $2.44M $658K +$111K +20.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 $2.33M $570K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 $619K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $593K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $547K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.